‘Gen Y’: Contemporary Mindset For Pharma Transformation

Global Pharma industry, for various reasons, is still not adequately aligned with the legitimate needs and expectations of the civil society, which are some of the key purposes for its existence, across the world. Consequently, there seems to be a gradually increasing … Continue reading

Patent Conundrum: Ignoring India Will Just Not be Foolhardy, Not An Option Either

The recent verdict of the Supreme Court against Novartis, upholding the decision of the Indian Patent Office (IPO) against grant of patent to their cancer drug Glivec, based on Section 3(d) of the Indian Patents Act, has caused a flutter … Continue reading